Elixir Medical Corp. announced enrollment completion of the 120-patient, pivotal clinical trial evaluating the safety and efficacy of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System. The scaffold is designed to resorb in the body within one to two years after implantation and return the patients’ coronary vessel to de novo state.
The Philips IntelliSpace Portal is an advanced visualization solution designed to simplify the way radiologists work, think and care for patients by delivering on the promise of real-time radiology.
October 29, 2012 — At RSNA 2012, GE Healthcare will unveil innovations in healthcare IT, including enhancements to Centricity PACS (picture archiving and communication system) and PACS-IW. The PACS-IW system aligns advanced visualization, breast imaging and intelligent tools with a unified desktop.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Boston Scientific Corporation has received regulatory approval to market the Reliance 4-Front lead, its next generation implantable defibrillation lead now available in Europe and Asia. Defibrillation leads are insulated wires that connect an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator to the heart for treatment of heart failure and sudden cardiac arrest.
October 29, 2012 — Brainlab released Buzz Digital OR, a major step forward in information integration for the surgical suite. Buzz encompasses a vast spectrum, from pure DICOM viewing to complete digital operating room (OR) functionality, including video management and documentation.
Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of SilverHawk/TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Biotronik began its European market release of BioMonitor, an implantable cardiac device designed for accurate and reliable monitoring and management of patients with atrial fibrillation (AF) or unexplained syncope.
October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc-99m) generators.
October 25, 2012 — InterSystems Corp., a provider of software for healthcare interoperability, and eHealth Technologies, a provider of imaging solutions for electronic health records (EHR) and health information exchange (HIE) solutions, entered a partnership to provide single-click access to diagnostic-quality images via the InterSystems HealthShare strategic informatics platform.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Avinger Inc., a medical device manufacturer of multi-functional catheters for crossing CTOs in patients with peripheral artery disease (PAD), announced its CONNECT II global clinical trial results at the Vascular Interventional Advances (VIVA) Conference 2012 in Las Vegas, Nev.
An online poll of physicians who lead hospitals, health systems and large group practices across the United States conducted after the first presidential debate found more preferred Republican challenger Mitt Romney's plan to reform Medicare than President Barack Obama's, with many still undecided.
October 23, 2012 — A study found that a tailored therapy approach that adjusts the loading dose of clopidogrel according to measured platelet reactivity is superior to prasugrel therapy in reducing high platelet reactivity (a risk factor for worse outcomes) in patients with acute coronary syndrome (ACS). Results of the trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 23, 2012 — In the DEBATE-SFA trial, researchers found that the use of a paclitaxel drug-eluting balloon (DEB) to widen the artery prior to implanting a self-expanding nitinol stent yielded a lower restenosis rate after one year. Results of the trial were presented at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the use of the new Gore septal occluder for inclusion in the Gore REDUCE clinical study.
At RSNA 2012, GE Healthcare will be showcasing a comprehensive portfolio of ultrasound products for use across a broad range of patient exam types. Among the products to be highlighted will be the newly enhanced Logiq E9, Logiq S8 and others in the LOGIQ family.
October 30, 2012
